Global CD40 Ligand Market Research Report 2019

Table of Contents

Executive Summary

1 CD40 Ligand Market Overview

• 1.1 Product Overview and Scope of CD40 Ligand
• 1.2 CD40 Ligand Segment by Type
  • 1.2.1 Global CD40 Ligand Production Growth Rate Comparison by Type (2014-2025)
  • 1.2.2 ISF-35
  • 1.2.3 LOAd-700
  • 1.2.4 MEDI-4920
  • 1.2.5 MegaCD40L
  • 1.2.6 Others
• 1.3 CD40 Ligand Segment by Application
  • 1.3.1 CD40 Ligand Consumption Comparison by Application (2014-2025)
  • 1.3.2 Hepatitis B
  • 1.3.3 Bladder Cancer
  • 1.3.4 Liver Cancer
  • 1.3.5 Ovarian Cancer
  • 1.3.6 Others
• 1.3 Global CD40 Ligand Market by Region
  • 1.3.1 Global CD40 Ligand Market Size Region
  • 1.3.2 North America Status and Prospect (2014-2025)
  • 1.3.3 Europe Status and Prospect (2014-2025)
  • 1.3.4 China Status and Prospect (2014-2025)
  • 1.3.5 Japan Status and Prospect (2014-2025)
  • 1.3.6 Southeast Asia Status and Prospect (2014-2025)
  • 1.3.7 India Status and Prospect (2014-2025)
• 1.4 Global CD40 Ligand Market Size
  • 1.4.1 Global CD40 Ligand Revenue (2014-2025)
  • 1.4.2 Global CD40 Ligand Production (2014-2025)

2 Global CD40 Ligand Market Competition by Manufacturers

• 2.1 Global CD40 Ligand Production Market Share by Manufacturers (2014-2019)
• 2.2 Global CD40 Ligand Revenue Share by Manufacturers (2014-2019)
• 2.3 Global CD40 Ligand Average Price by Manufacturers (2014-2019)
• 2.4 Manufacturers CD40 Ligand Production Sites, Area Served, Product Types
• 2.5 CD40 Ligand Market Competitive Situation and Trends
  • 2.5.1 CD40 Ligand Market Concentration Rate
  • 2.5.2 CD40 Ligand Market Share of Top 3 and Top 5 Manufacturers
  • 2.5.3 Mergers & Acquisitions, Expansion

3 Global CD40 Ligand Production Market Share by Regions

• 3.1 Global CD40 Ligand Production Market Share by Regions
• 3.2 Global CD40 Ligand Revenue Market Share by Regions (2014-2019)
• 3.3 Global CD40 Ligand Production, Revenue, Price and Gross Margin (2014-2019)
• 3.4 North America CD40 Ligand Production
  • 3.4.1 North America CD40 Ligand Production Growth Rate (2014-2019)
  • 3.4.2 North America CD40 Ligand Production, Revenue, Price and Gross Margin (2014-2019)
• 3.5 Europe CD40 Ligand Production
  • 3.5.1 Europe CD40 Ligand Production Growth Rate (2014-2019)
  • 3.5.2 Europe CD40 Ligand Production, Revenue, Price and Gross Margin (2014-2019)
• 3.6 China CD40 Ligand Production (2014-2019)
  • 3.6.1 China CD40 Ligand Production Growth Rate (2014-2019)
  • 3.6.2 China CD40 Ligand Production, Revenue, Price and Gross Margin (2014-2019)
• 3.7 Japan CD40 Ligand Production (2014-2019)
  • 3.7.1 Japan CD40 Ligand Production Growth Rate (2014-2019)
  • 3.7.2 Japan CD40 Ligand Production, Revenue, Price and Gross Margin (2014-2019)

4 Global CD40 Ligand Consumption by Regions

• 4.1 Global CD40 Ligand Consumption by Regions
• 4.2 North America CD40 Ligand Consumption (2014-2019)
• 4.3 Europe CD40 Ligand Consumption (2014-2019)
• 4.4 China CD40 Ligand Consumption (2014-2019)
• 4.5 Japan CD40 Ligand Consumption (2014-2019)

5 Global CD40 Ligand Production, Revenue, Price Trend by Type

• 5.1 Global CD40 Ligand Production Market Share by Type (2014-2019)
• 5.2 Global CD40 Ligand Revenue Market Share by Type (2014-2019)
• 5.3 Global CD40 Ligand Price by Type (2014-2019)
• 5.4 Global CD40 Ligand Production Growth by Type (2014-2019)

6 Global CD40 Ligand Market Analysis by Applications

• 6.1 Global CD40 Ligand Consumption Market Share by Application (2014-2019)
• 6.2 Global CD40 Ligand Consumption Growth Rate by Application (2014-2019)

7 Company Profiles and Key Figures in CD40 Ligand Business

• 7.1 Biogen, Inc.
  • 7.1.1 Biogen, Inc. CD40 Ligand Production Sites and Area Served
  • 7.1.2 CD40 Ligand Product Introduction, Application and Specification
  • 7.1.3 Biogen, Inc. CD40 Ligand Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.1.4 Main Business and Markets Served
• 7.2 Bristol-Myers Squibb Company
  • 7.2.1 Bristol-Myers Squibb Company CD40 Ligand Production Sites and Area Served
  • 7.2.2 CD40 Ligand Product Introduction, Application and Specification
  • 7.2.3 Bristol-Myers Squibb Company CD40 Ligand Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.2.4 Main Business and Markets Served
• 7.3 eTheRNA Immunotherapies NV
  • 7.3.1 eTheRNA Immunotherapies NV CD40 Ligand Production Sites and Area Served
  • 7.3.2 CD40 Ligand Product Introduction, Application and Specification
  • 7.3.3 eTheRNA Immunotherapies NV CD40 Ligand Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.3.4 Main Business and Markets Served
• 7.4 ImmuNext, Inc.
  • 7.4.1 ImmuNext, Inc. CD40 Ligand Production Sites and Area Served
  • 7.4.2 CD40 Ligand Product Introduction, Application and Specification
  • 7.4.3 ImmuNext, Inc. CD40 Ligand Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.4.4 Main Business and Markets Served
• 7.5 Juno Therapeutics Inc.
  • 7.5.1 Juno Therapeutics Inc. CD40 Ligand Production Sites and Area Served
  • 7.5.2 CD40 Ligand Product Introduction, Application and Specification
  • 7.5.3 Juno Therapeutics Inc. CD40 Ligand Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.5.4 Main Business and Markets Served
• 7.6 MedImmune, LLC
  • 7.6.1 MedImmune, LLC CD40 Ligand Production Sites and Area Served
  • 7.6.2 CD40 Ligand Product Introduction, Application and Specification
  • 7.6.3 MedImmune, LLC CD40 Ligand Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.6.4 Main Business and Markets Served
• 7.7 Targovax AS
  • 7.7.1 Targovax AS CD40 Ligand Production Sites and Area Served
  • 7.7.2 CD40 Ligand Product Introduction, Application and Specification
  • 7.7.3 Targovax AS CD40 Ligand Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.7.4 Main Business and Markets Served
• 7.8 XL-protein GmbH
  • 7.8.1 XL-protein GmbH CD40 Ligand Production Sites and Area Served
  • 7.8.2 CD40 Ligand Product Introduction, Application and Specification
  • 7.8.3 XL-protein GmbH CD40 Ligand Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.8.4 Main Business and Markets Served

8 CD40 Ligand Manufacturing Cost Analysis

• 8.1 CD40 Ligand Key Raw Materials Analysis
  • 8.1.1 Key Raw Materials
  • 8.1.2 Price Trend of Key Raw Materials
  • 8.1.3 Key Suppliers of Raw Materials
• 8.2 Proportion of Manufacturing Cost Structure
• 8.3 Manufacturing Process Analysis of CD40 Ligand
• 8.4 CD40 Ligand Industrial Chain Analysis

9 Marketing Channel, Distributors and Customers

• 9.1 Marketing Channel
  • 9.1.1 Direct Marketing
  • 9.1.2 Indirect Marketing
• 9.2 CD40 Ligand Distributors List
• 9.3 CD40 Ligand Customers

10 Market Dynamics

• 10.1 Market Trends
• 10.2 Opportunities
• 10.3 Market Drivers
• 10.4 Challenges
• 10.5 Influence Factors

11 Global CD40 Ligand Market Forecast

• 11.1 Global CD40 Ligand Production, Revenue Forecast
  • 11.1.1 Global CD40 Ligand Production Growth Rate Forecast (2019-2025)
  • 11.1.2 Global CD40 Ligand Revenue and Growth Rate Forecast (2019-2025)
  • 11.1.3 Global CD40 Ligand Price and Trend Forecast (2019-2025)
• 11.2 Global CD40 Ligand Production Forecast by Regions (2019-2025)
  • 11.2.1 North America CD40 Ligand Production, Revenue Forecast (2019-2025)
  • 11.2.2 Europe CD40 Ligand Production, Revenue Forecast (2019-2025)
  • 11.2.3 China CD40 Ligand Production, Revenue Forecast (2019-2025)
  • 11.2.4 Japan CD40 Ligand Production, Revenue Forecast (2019-2025)
• 11.3 Global CD40 Ligand Consumption Forecast by Regions (2019-2025)
  • 11.3.1 North America CD40 Ligand Consumption Forecast (2019-2025)
  • 11.3.2 Europe CD40 Ligand Consumption Forecast (2019-2025)
  • 11.3.3 China CD40 Ligand Consumption Forecast (2019-2025)
  • 11.3.4 Japan CD40 Ligand Consumption Forecast (2019-2025)
• 11.4 Global CD40 Ligand Production, Revenue and Price Forecast by Type (2019-2025)
• 11.5 Global CD40 Ligand Consumption Forecast by Application (2019-2025)

12 Research Findings and Conclusion

13 Methodology and Data Source

• 13.1 Methodology/Research Approach
  • 13.1.1 Research Programs/Design
  • 13.1.2 Market Size Estimation
  • 13.1.3 Market Breakdown and Data Triangulation
• 13.2 Data Source
  • 13.2.1 Secondary Sources
  • 13.2.2 Primary Sources
• 13.3 Author List